Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
University Health Network · University of Toronto · +19 more institutions
Abstract
Pain medication plays an important role in the treatment of acute and chronic pain conditions, but some drugs, opioids in particular, have been overprescribed or prescribed without adequate safeguards, leading to an alarming rise in medication-related overdose deaths. The NIH Helping to End Addiction Long-term (HEAL) Initiative is a trans-agency effort to provide scientific solutions to stem the opioid crisis. One component of the initiative is to support biomarker discovery and rigorous validation in collaboration with industry leaders to accelerate high-quality clinical research into neurotherapeutics and pain. The use of objective biomarkers and clinical trial end points throughout the drug discovery and…
Citation impact
- FWCI
- 29.19
- Percentile
- 100%
- References
- 241
Authors
26- KDKaren D. DavisCorresponding
University Health Network, University of Toronto, Toronto Western Hospital, Ontario Brain Institute
- NANima Aghaeepour
Stanford University
- AHAndrew H. Ahn
Teva Pharmaceuticals (United States)
- MSMartin S. Angst
Stanford University
- DBDavid Borsook
Harvard University, Center for Pain and the Brain
Topics & keywords
- Medicine
- Addiction
- Drug development
- Biomarker discovery
- Clinical trial
- Agency (philosophy)
- Chronic pain
- Intensive care medicine
Funding
- NINational Institutes of Health
- NINational Institute on Alcohol Abuse and Alcoholism
- NINational Institute on Drug Abuse
- NCNational Cancer Institute
- NINational Institute of Nursing Research
- NINational Institute of Neurological Disorders and Stroke
- NINational Institute of Dental and Craniofacial Research
- OOOffice of Research on Women's Health
- NCNational Center for Complementary and Integrative Health